Looking for an LAAC specialised centre? Find a centre near you
Skip to main content
A female doctor smiles, below her a collage of doctors helping patients with Afib.

THE WATCHMANTM LEFT ATRIAL APPENDAGE CLOSURE IMPLANT

The WATCHMANTM  Implant: a lifelong solution for stroke protection.

Reduce long-term stroke risk for your NVAF patients with a single solution freeing them from OACs and associated risks.

One Time. For a Lifetime.

The WATCHMANTM Implant is the one-time, minimally invasive procedure that protects your atrial fibrillation (AFib) patients for life:

  • against stroke risk.
  • against bleeding risks associated with oral anticoagulant (OAC) treatment

Learn more about the WATCHMANTM procedure

WATCHMAN FLX Pro LAAC device.
More than 600.000 AFib patients have been successfully treated with WATCHMAN

Over 600.000 AFib patients globally have left blood thinners behind, replacing OACs with the WATCHMANᵀᴹ Implant.¹

Icon of a hand holding a heart.

Proven1

600.000+

patients treated

20+

years clinical experience

Icon of a wheel that turns efficiently.

Safe2

99%

implant success rate*

0.5%

major adverse event rate†

Checkmark icon in a circle.

Effective2

96.2%

of patients discontinued OACs at 45 days

Protect your patients: stroke risk reduction without the risks of OACs

Learn more about the WATCHMANᵀᴹ Implant and hear from cardiologists on this safe, OAC alternative for stroke risk reduction.

The world’s most studied and implanted LAAC device  

Learn more about WATCHMANTM and Stroke prevention

Act now: Manage stroke risk in AF patients without a lifetime dependance on OACs. Explore alternative non-invasive treatment options today.
Icon of a magnifying glass with bars.

Atrial fibrilation and stroke prevention

Learn about the difference of the WATCHMANᵀᴹ implant

Understand the difference

Icon of an arrow with a line going down.

Access resources

Access WATCHMANᵀᴹ resources in the referring HCP download centre

Icon of a person wearing a headset.

Talk to someone

Connect with a local representative to learn about the WATCHMANᵀᴹ Implant

*Procedure success defined as successful delivery and release of a WATCHMAN FLX Device into the LAA.

†Occurrence of one of the following events between the time of implant and within 7 days following the procedure or by hospital discharge, whichever is later: all-cause death, ischemic stroke, systemic embolism, or device or procedure related events requiring open cardiac surgery or major endovascular intervention.

References:

1. Represents all WATCHMAN models.

2. Kar, S., et al, Primary Outcome Evaluation of the Next Generation LAAC Device: Results from the PINNACLE FLX Trial, Circulation, 2021.

CAUTION: The law restricts these devices to sale by or on the order of a physician. Indications, contraindications, warnings, and instructions for use can be found in the product labelling supplied with each device. Products shown for INFORMATION purposes only and may not be approved or for sale in certain countries. This material not intended for use in France.